Cuiju Tang

Nanjing First Hospital
Professor, Medicine And Medical Sciences
China, People's Republic of

My Publications

Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versu...

OncoTargets and Therapy
August 2016